Literature DB >> 28815760

Impact Microindentation: Consistency of Serial Measurements and Alterations in Patients With Paget's Disease of the Tibia.

Frank Malgo1, Neveen At Hamdy1, Socrates E Papapoulos1, Natasha M Appelman-Dijkstra1.   

Abstract

Impact microindentation (IMI) is a new technique for the in vivo measurement of tissue-level properties of cortical bone in humans. To address issues related to the proper application of IMI in clinical practice and to directly examine cortical bone properties in patients with tibia pathology, we studied 11 subjects without tibia pathology and nine patients with Paget's disease of the tibia in biochemical remission after bisphosphonate treatment. Serial indentations in the tibias of both legs were performed in all subjects by a single operator until 10 adequate measurements were obtained in each tibia. In patients without Paget's disease (7 men and 4 women; mean age, 61.9 years; range, 51 to 72 years), there was no difference in mean bone material strength index (BMSi) between the dominant and nondominant leg (82.1 ± 1.3 and 81.4 ± 1.3, respectively; p = 0.606). In each individual subject studied, sequential indentations in both legs showed no trends for higher or lower values with time. The standard deviation of unnormalized bone material strength (BMSu) was also comparable between the dominant and nondominant tibia (5.3 and 4.5, respectively; p = 0.657). In patients with Paget's disease (4 men and 5 women; mean age, 69.5 years; range, 55 to 87 years), mean BMSi of the Pagetic tibia was lower, albeit nonsignificantly, than that of the contralateral nonaffected tibia (74.7 ± 1.7 and 78.7 ± 1.3, respectively; p = 0.120). In contrast to subjects without Paget's disease, the SD of adequate BMSu values was significantly larger in the Pagetic tibia compared to that of the non-Pagetic tibia (7.6 versus 5.0, respectively, p = 0.008). These results highlight the consistency of serial IMI measurements as performed by a single operator in the presence as well as absence of tibia pathology and illustrate that the method is able to capture alterations of tissue-level cortical bone properties in patients with Paget's disease of the tibia.
© 2017 The Authors.Journal of Bone and Mineral Research Published by Wiley Periodicals Inc. © 2017 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals Inc.

Entities:  

Keywords:  IMPACT MICROINDENTATION; OSTEOPROBE; PAGET'S DISEASE OF BONE; REFERENCE POINT INDENTATION

Mesh:

Year:  2017        PMID: 28815760     DOI: 10.1002/jbmr.3239

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  5 in total

1.  Treatments of osteoporosis increase bone material strength index in patients with low bone mass.

Authors:  M Schoeb; F Malgo; J J M Peeters; E M Winter; S E Papapoulos; N M Appelman-Dijkstra
Journal:  Osteoporos Int       Date:  2020-04-08       Impact factor: 4.507

2.  Microhardness distribution of the tibial diaphysis and test site selection for reference point indentation technique.

Authors:  Jianzhao Wang; Bing Yin; Guobin Liu; Sheng Li; Xiaojuan Zhang; Zusheng Hu; Weiwei Wu; Yingze Zhang
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

3.  Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures.

Authors:  M Schoeb; E M Winter; F Malgo; I B Schipper; R J P van der Wal; S E Papapoulos; N M Appelman-Dijkstra
Journal:  Osteoporos Int       Date:  2022-03-21       Impact factor: 5.071

4.  Added Value of Impact Microindentation in the Evaluation of Bone Fragility: A Systematic Review of the Literature.

Authors:  Manuela Schoeb; Neveen A T Hamdy; Frank Malgo; Elizabeth M Winter; Natasha M Appelman-Dijkstra
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-07       Impact factor: 5.555

5.  Associations between Bone Material Strength Index, Calcaneal Quantitative Ultrasound, and Bone Mineral Density in Men.

Authors:  Pamela Rufus-Membere; Kara L Holloway-Kew; Adolfo Diez-Perez; Mark A Kotowicz; Julie A Pasco
Journal:  J Endocr Soc       Date:  2020-11-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.